middle.news
Optiscan Launches InSpecta™ in US Veterinary Market After FDA Approval
8:20am on Tuesday 7th of July, 2026 AEST
•
Healthcare
Read Story
Optiscan Launches InSpecta™ in US Veterinary Market After FDA Approval
8:20am on Tuesday 7th of July, 2026 AEST
Key Points
First FDA-cleared clinical device launched in US veterinary market
InSpecta™ enables real-time cellular imaging at point of care
Launch showcased at AVMA Convention 2026 in California
Establishes regulatory and commercial foothold for future products
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE